Levent Akduman
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Levent Akduman has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Henry J. Kaplan
Department of Ophthalmology and Visual Sciences Washington University School of Medicine, St. Louis, Mo., USA
2 shared publications Amanda J. Bissell
O'Donnell Eye Institute, St. Louis, Missouri, USA
1 shared publicationAndrew J. Barkmeier
Cullen Eye Institute, Baylor College of Medicine
1 shared publicationBenjamin J. Ernst
Saint Louis University Eye Institute, 1755 S Grand Blvd.,St. Louis, MO 63104, USA
1 shared publicationDimple Modi
Saint Louis University School of Medicine, Department of Ophthalmology, Saint Louis University Eye Institute, St. Louis, Missouri, USA
1 shared publicationEbru Nevin Cetin
Department of Ophthalmology, Saint Louis University, Saint Louis, MO, USA
1 shared publication
Latest Publications
- Open Access
- 1 February 2013
- Published by Taylor & Francis in Ocular Immunology and Inflammation
- Vol. 21 (1) , 87-89
Spontaneous Dissociation and Dislocation of Retisert Pellet
Purpose: To report 4 cases of spontaneous Retisert pellet dislocation. Design: Retrospective case series. Methods: Description of cases. Results: In all 4 cases, the time of Retisert implantation was 3–6 years prior to presentation. One case was complicated by retinal commotio and a retinal tear; another was complicated by corneal endothelial failure, due to dislocation of the pellet into the anterior chamber. Conclusion: Spontaneous pellet separation may occur with Retisert as a late complication. It is unclear whether these dislocations are from a manufacturing fault or are related to extended intraocular exposure.
- 1 February 2013
- Published by Taylor & Francis in Ocular Immunology and Inflammation
- Vol. 21 (1) , 87-89
Open AccessSpontaneous Dissociation and Dislocation of Retisert Pellet
Purpose: To report 4 cases of spontaneous Retisert pellet dislocation. Design: Retrospective case series. Methods: Description of cases. Results: In all 4 cases, the time of Retisert implantation was 3–6 years prior to presentation. One case was complicated by retinal commotio and a retinal tear; another was complicated by corneal endothelial failure, due to dislocation of the pellet into the anterior chamber. Conclusion: Spontaneous pellet separation may occur with Retisert as a late complication. It is unclear whether these dislocations are from a manufacturing fault or are related to extended intraocular exposure.
- 3 September 2009
- Published by Springer Nature in International Ophthalmology
- Vol. 30 (3) , 267-270
Optical coherence tomography-based intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration
To evaluate optical coherence tomography (OCT)-based intravitreal ranibizumab treatment for neovascular age-related macular degeneration (AMD), the charts of consecutive patients who received intravitreal ranibizumab for subfoveal choroidal neovascularization due to AMD were retrospectively reviewed. Patients with less than 6 months follow-up were excluded. OCT was performed at baseline and at monthly intervals for induction therapy. Injections were given monthly until no improvement was observed between successive OCTs. In the maintenance period, reinjections were performed for any recurrence of macular fluid on OCT. Main outcome measures were visual acuity and number of injections given. Twenty-five eyes of 22 patients with mean follow-up of 16 months [standard deviation (SD) = 3.7 months] had mean improvement of 1.6 lines of Snellen visual acuity (SD 2.9, 95% confidence interval 0.48–2.9, P = 0.008). Visual acuity was stable (≤3 lines of visual acuity lost) in 22 eyes (88%). Nine eyes (36%) gained ≥3 lines. Three eyes (12%) lost ≥3 lines. A mean of 6.0 (SD 2.7) injections were given over a follow-up period ranging from 8 to 21 months. We conclude that OCT-based intravitreal ranibizumab treatment for neovascular AMD offered excellent visual acuity results and reduced the number of injections compared with monthly dosing.
- 3 September 2009
- Published by Springer Nature in International Ophthalmology
- Vol. 30 (3) , 267-270
Optical coherence tomography-based intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration
To evaluate optical coherence tomography (OCT)-based intravitreal ranibizumab treatment for neovascular age-related macular degeneration (AMD), the charts of consecutive patients who received intravitreal ranibizumab for subfoveal choroidal neovascularization due to AMD were retrospectively reviewed. Patients with less than 6 months follow-up were excluded. OCT was performed at baseline and at monthly intervals for induction therapy. Injections were given monthly until no improvement was observed between successive OCTs. In the maintenance period, reinjections were performed for any recurrence of macular fluid on OCT. Main outcome measures were visual acuity and number of injections given. Twenty-five eyes of 22 patients with mean follow-up of 16 months [standard deviation (SD) = 3.7 months] had mean improvement of 1.6 lines of Snellen visual acuity (SD 2.9, 95% confidence interval 0.48–2.9, P = 0.008). Visual acuity was stable (≤3 lines of visual acuity lost) in 22 eyes (88%). Nine eyes (36%) gained ≥3 lines. Three eyes (12%) lost ≥3 lines. A mean of 6.0 (SD 2.7) injections were given over a follow-up period ranging from 8 to 21 months. We conclude that OCT-based intravitreal ranibizumab treatment for neovascular AMD offered excellent visual acuity results and reduced the number of injections compared with monthly dosing.
- Open Access
- 1 August 2009
- Published by Taylor & Francis in Clinical Ophthalmology
- Vol. 3, 465-70
Efficacy of patterned scan laser in treatment of macular edema and retinal neovascularization
Peer reviewed article authored by (Dimple Modi, Paulpoj Chiranand, Levent Akduman). Read article or submit your manuscript for publishing.
- 1 August 2009
- Published by Taylor & Francis in Clinical Ophthalmology
- Vol. 3, 465-70
Open AccessEfficacy of patterned scan laser in treatment of macular edema and retinal neovascularization
Peer reviewed article authored by (Dimple Modi, Paulpoj Chiranand, Levent Akduman). Read article or submit your manuscript for publishing.
- 1 January 2009
- Published by Taylor & Francis in Ocular Immunology and Inflammation
- Vol. 17 (4) , 265-266
Can We Be More Objective in Determining the Response to Treatment in Uveitis Patients Aside From Recording Anterior Chamber Reaction?
Several subjective and arbitrary grading methods are used in assessing cell and flare in uveitis. Clinicians are in need of an objective method of determining and monitoring active inflammation. We studied the correlation of changes in macular thickness between the visits and compared the change to visual acuity (VA), cell, flare, or the inflammation index (which we defined as cell+flare). The best correlations were between macular thickness and VA, and between the inflammation index and macular thickness. Macular thickness as seen on OCT, may be more objective and correlate more closely with VA than measurement of flare and/or cell.
- 1 January 2009
- Published by Taylor & Francis in Ocular Immunology and Inflammation
- Vol. 17 (4) , 265-266
Can We Be More Objective in Determining the Response to Treatment in Uveitis Patients Aside From Recording Anterior Chamber Reaction?
Several subjective and arbitrary grading methods are used in assessing cell and flare in uveitis. Clinicians are in need of an objective method of determining and monitoring active inflammation. We studied the correlation of changes in macular thickness between the visits and compared the change to visual acuity (VA), cell, flare, or the inflammation index (which we defined as cell+flare). The best correlations were between macular thickness and VA, and between the inflammation index and macular thickness. Macular thickness as seen on OCT, may be more objective and correlate more closely with VA than measurement of flare and/or cell.
- 24 May 2005
- Published by Wiley in Acta Ophthalmologica Scandinavica
- Vol. 83 (4) , 514-515
Bilateral geographic atrophy: Spontaneous visual improvement after loss of vision in the fellow eye
- 24 May 2005
- Published by Wiley in Acta Ophthalmologica Scandinavica
- Vol. 83 (4) , 514-515
Bilateral geographic atrophy: Spontaneous visual improvement after loss of vision in the fellow eye
- 1 February 1998
- Published by SLACK, Inc. in Ophthalmic Surgery, Lasers and Imaging Retina
- Vol. 29 (2) , 126-139
Laser Photocoagulation and Glucose Metabolism in Idiopathic Juxtafoveolar Retinal Telangiectasis
- 1 February 1998
- Published by SLACK, Inc. in Ophthalmic Surgery, Lasers and Imaging Retina
- Vol. 29 (2) , 126-139
Laser Photocoagulation and Glucose Metabolism in Idiopathic Juxtafoveolar Retinal Telangiectasis
- 1 November 1997
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 124 (5) , 699-702
Macular Ischemia as a Cause of Decreased Vision in a Patient With Acquired Immunodeficiency Syndrome
- 1 November 1997
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 124 (5) , 699-702
Macular Ischemia as a Cause of Decreased Vision in a Patient With Acquired Immunodeficiency Syndrome
- 1 July 1997
- Vol. 16 (4) , 177-82
Prevalence of uveitis in an outpatient juvenile arthritis clinic: onset of uveitis more than a decade after onset of arthritis.
- 1 July 1997
- Vol. 16 (4) , 177-82
Prevalence of uveitis in an outpatient juvenile arthritis clinic: onset of uveitis more than a decade after onset of arthritis.
- 1 January 1997
- Vol. 17 (2) , 167-8
Major blinding complication of acquired immune deficiency syndrome (AIDS)
- 1 January 1997
- Vol. 17 (2) , 167-8
Major blinding complication of acquired immune deficiency syndrome (AIDS)